Clinical Trial Update: Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacodynamic characteristics of an exploratory insulin degludec formulation in male subjects with Type 1 diabetes; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Tresiba (insulin degludec) (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED